Author:
Mircioiu C.,Perju A.,Neagu A.,Griu E.,Calin G.,Miron D. S.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Reference21 articles.
1. Check J.H., Rankin A., Teichman M. (1986): The risk of fetal anomalies as a result of progesterone therapy during pregnancy. Fertil. Steril., 45, 575–577.
2. Lobo R.A., Whithead M.I. (Eds) 1989: Proceedings of the consensus development conference on progesterone. New York: Worldwide Medical Group.
3. Morville R., Dray F., Reynier J., Barrat J. (1982): Biodisponibilité de la progesterone naturelle administrée par voie orale. J. Gynecol. Obstet. Biol. Reprod., 11, 355–363.
4. Ottosson U.B., Carlstrom K., Damber J.E., Von Schoultz B. (1984): Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration. Br. J. Obstet. Gynaecol., 91, 1111–1119.
5. Padwick M., Endacott J., Manson C., Whithead M. (1986): Adsorption and metabolism of oral progesterone when administered twice daily. Fertil. Steril., 46, 402–407.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献